Boyeong Song

Seoul National University — South Korea

Immunology and Microbiology · Life Sciences

9h-index473citations37works1.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(17), Immune Cell Function and Interaction(17), Immune cells in cancer(14), Bone and Dental Protein Studies(6), Cancer Immunotherapy and Biomarkers(5)

Publications37 total

The Ad5/35 Platform-Based Vaccines for SARS-CoV-2: A Strategy to Counter Evolving Variants 2324
The Journal of Immunology·2025Open Access
Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants
Journal of Medical Virology·2025· 2 cited
Supplementary Figures from Activation of NKT Cells in an Anti-PD-1–Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
2025Open Access
Data from Activation of NKT Cells in an Anti-PD-1–Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
2025Open Access
Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study
Frontiers in Immunology·2024· 5 citedOpen Access
Data from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Data from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Data from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Supplementary Figures from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figure 6 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Supplemental data from Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
2023Open Access
Supplementary Figures 1-5 and 7-8 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Supplemental data from Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
2023Open Access
Supplementary Figures 1-5 and 7-8 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Supplementary Figures from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Data from Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
2023Open Access
Data from Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
2023Open Access
Data from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Supplementary Figure 6 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
2023Open Access
Inhibition of topoisomerase I shapes antitumor immunity through the induction of monocyte-derived dendritic cells
Cancer Letters·2021· 17 cited
page 1 of 2Next →

Frequent Co-authors

Chang‐Yuil Kang(29), Insu Jeon(21), Eun‐Kyung Kim(13), Kwangsoo Shin(12), Choong‐Hyun Koh(11), Young‐Jun Park(11), Hyungseok Seo(9), Yeonseok Chung(9), Il‐Kyu Kim(8), Eun‐Ah Bae(7), Kwang Soon Kim(7), Se Hwan Yang(7), Doo Hyun Chung(7), Jonathan Sprent(7), Jaeho Cho(7), Young Chul Sung(7), Hyungseok Seo(6), Yun-Sun Kim(6), Jung-Mi Lee(6), Ga-Eun Lee(6)